At a glance
ClinicalIndex Comparison RecordN/ACompleted· 144 enrolled
Drug / intervention
Mindfulness session(s)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mindfulness During COVID-19 - Remote Mindfulness Sessions
In Brief
A clinical study evaluating Mindfulness session(s) for Migraine Disorders and 2 related conditions. Completed, enrolled 144 participants across 1 site.
Detailed Summary
The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Disorders, Stress, Anxiety
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMar 2020
First PostedMar 2020
Primary CompletionJul 2020
TodayJul 2026
First PostedMar 24, 2020
Enrollment StartMar 23, 2020
Primary CompletionJul 28, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.3 years ago
Interventions
Mindfulness session(s)behavioral
The sessions will be hosted online using an online platform (such as through webex, private YouTube page, Facebook live, etc).